Events › Health

Melanoma mRNA cancer vaccine Developing

First reported Oct 22, 2:35 PM ET by Reuters · ongoing, 27 hours so far

Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40% (opens the original story in a new tab)

ReutersOct 22, 2:35 PM

8 / 27 outletsNot yet: Bloomberg, Fox News, The Epoch Times, Newsweek +15

Videos: 1
Articles: 8
YouTube views: 6,391
Running: 27h

How the story spread

New articles per hour (ET) and YouTube views per hour (right axis); dots mark the first report and the busiest hour

← Swipe to see the whole chart →

New articlesYouTube views per hour

How each outlet covered it

8 outlets, in order of their first story; headlines link to the original

← Swipe to see the whole table →

Outlet	First seen	Articles	Videos	First headline
Reuters	Oct 22, 2:35 PM First	1	0	Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40%
The New York Times	Oct 22, 4:01 PM	1	0	Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
CNN	Oct 22, 4:26 PM	1	0	Experimental mRNA vaccine cuts risk melanoma returns by 42%
Newsmax	Oct 22, 5:36 PM	1	0	Vaccine Cuts Melanoma Recurrence, Death by Over 40%
TIME	Oct 22, 7:54 PM	1	0	A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
Associated Press	Oct 23, 12:30 AM	1	1	A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
New York Post	Oct 23, 3:26 AM	1	0	First-of-its-kind cancer vaccine helps reduce chances of melanoma patients' tumors returning: study
ABC News	Oct 23, 1:22 PM	1	0	Cancer vaccine reduces melanoma from returning by 42%, data shows

Not yet: Bloomberg, Fox News, The Epoch Times, Newsweek, Los Angeles Times, Breitbart, The Hill, Business Insider, CNBC, NBC News, HuffPost, CBS News, MS NOW, The Wall Street Journal, Politico, The Washington Post, USA Today, NTD, Vox